SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of ...

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers ...

ProPhase Labs, Inc. PRPH shares rallied 9.1% in the last trading session to close at $14.15. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Garden City, NY, Feb. 06, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics, genomics and biotech company, today provided ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an ...

ProPhase Labs press release (NASDAQ:PRPH): FY GAAP EPS of $1.02 misses by $0.10. Revenue of $122.65M (+55.2% Y/Y) beats by $1.31M. cash and cash equivalents and restricted cash as of December 31 ...

--ProPhase Labs, Inc., a next-generation biotech, genomics and diagnostics company, is pleased to announce that Ted Karkus, CEO, has been named one of Inc Magazine’ s 10 Most Innovative ...

In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, reaching a price level of $1.99. This latest dip underscores a difficult period for the company ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...

NEW YORK (MarketWatch) -- Matrixx Initiatives Inc. on Tuesday increased its buyout offer for ProPhase Labs Inc. by 14% to $1.60 a share in cash from its earlier offer of $1.40 a share. Shares of ...